N. Zealand LCT Co-Founder Sees Insulin-Making Pig Cells In 2013
This article was originally published in PharmAsia News
Executive SummaryNew Zealand co-founder of Living Cell Technologies expects a pig-cell treatment for Type 1 diabetes to reach the market in about two years
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.